AP544A - Compositions for rectal administration - Google Patents

Compositions for rectal administration Download PDF

Info

Publication number
AP544A
AP544A APAP/P/1994/000643A AP9400643A AP544A AP 544 A AP544 A AP 544A AP 9400643 A AP9400643 A AP 9400643A AP 544 A AP544 A AP 544A
Authority
AP
ARIPO
Prior art keywords
methyl
suppository
active ingredient
rectal administration
pharmaceutically acceptable
Prior art date
Application number
APAP/P/1994/000643A
Other languages
English (en)
Other versions
AP9400643A0 (en
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Laboratoires Glaxo S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo S A filed Critical Laboratoires Glaxo S A
Publication of AP9400643A0 publication Critical patent/AP9400643A0/xx
Application granted granted Critical
Publication of AP544A publication Critical patent/AP544A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
APAP/P/1994/000643A 1993-05-25 1994-05-23 Compositions for rectal administration AP544A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (2)

Publication Number Publication Date
AP9400643A0 AP9400643A0 (en) 1994-07-31
AP544A true AP544A (en) 1996-10-11

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000643A AP544A (en) 1993-05-25 1994-05-23 Compositions for rectal administration

Country Status (38)

Country Link
US (1) US5741806A (is)
EP (1) EP0700290B1 (is)
JP (1) JP2965703B2 (is)
KR (1) KR100297212B1 (is)
CN (1) CN1106194C (is)
AP (1) AP544A (is)
AT (1) ATE183643T1 (is)
AU (1) AU680918B2 (is)
BE (1) BE1007158A3 (is)
BR (1) BR1100046A (is)
CA (1) CA2162919C (is)
CO (1) CO4230094A1 (is)
CY (1) CY2411B1 (is)
CZ (1) CZ291041B6 (is)
DE (1) DE69420266T2 (is)
DK (1) DK0700290T3 (is)
EC (1) ECSP941088A (is)
ES (1) ES2136198T3 (is)
FR (1) FR2705569B1 (is)
GB (2) GB9310756D0 (is)
GR (1) GR3031669T3 (is)
HR (2) HRP940315B1 (is)
HU (1) HU227121B1 (is)
IE (1) IE80632B1 (is)
IL (1) IL109749A (is)
IS (1) IS1868B (is)
IT (1) IT1272990B (is)
MY (1) MY111445A (is)
NO (1) NO306448B1 (is)
NZ (1) NZ267415A (is)
PE (1) PE13395A1 (is)
PL (1) PL175578B1 (is)
RU (1) RU2132684C1 (is)
SA (1) SA94150003B1 (is)
SG (1) SG48119A1 (is)
SI (1) SI0700290T1 (is)
WO (1) WO1994027599A1 (is)
ZA (1) ZA943593B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK19062000A3 (sk) * 1998-06-15 2001-07-10 Sepracor, Inc. Použitie (-)-norcisapridu alebo jeho farmaceuticky prijateľnej soli, v podstate bez jeho (+) stereoizoméru, na liečenie apnoe, bulímie a iných porúch
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
TR200103056T2 (tr) 1998-06-15 2002-06-21 Sepracor Inc. Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı.
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6555543B2 (en) * 2000-08-04 2003-04-29 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983621A (en) * 1988-07-07 1991-01-08 Glaxo Group Limited Medicaments
WO1992004012A1 (en) * 1990-09-10 1992-03-19 Alza Corporation Antiemetic therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) * 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983621A (en) * 1988-07-07 1991-01-08 Glaxo Group Limited Medicaments
WO1992004012A1 (en) * 1990-09-10 1992-03-19 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
HUT74867A (en) 1997-02-28
CZ308595A3 (en) 1996-06-12
IS4168A (is) 1994-11-26
NZ267415A (en) 1997-10-24
CA2162919A1 (en) 1994-12-08
FR2705569A1 (fr) 1994-12-02
HRP940315B1 (en) 2000-12-31
EP0700290A1 (en) 1996-03-13
IE80632B1 (en) 1998-10-21
SG48119A1 (en) 1998-04-17
MY111445A (en) 2000-05-31
CN1106194C (zh) 2003-04-23
CA2162919C (en) 1999-07-20
DE69420266T2 (de) 1999-12-09
ZA943593B (en) 1995-02-13
ES2136198T3 (es) 1999-11-16
CY2411B1 (en) 2004-11-12
IS1868B (is) 2003-05-02
NO954783D0 (no) 1995-11-24
IL109749A (en) 1999-03-12
HU227121B1 (en) 2010-07-28
NO954783L (no) 1995-11-24
ECSP941088A (es) 1994-11-16
PE13395A1 (es) 1995-05-25
CN1124454A (zh) 1996-06-12
PL311721A1 (en) 1996-03-04
IL109749A0 (en) 1994-08-26
JP2965703B2 (ja) 1999-10-18
GB2279008A (en) 1994-12-21
ITRM940322A0 (it) 1994-05-24
CZ291041B6 (cs) 2002-12-11
SA94150003B1 (ar) 2005-04-11
BR1100046A (pt) 1999-11-23
FR2705569B1 (fr) 1995-11-10
PL175578B1 (pl) 1999-01-29
AP9400643A0 (en) 1994-07-31
DK0700290T3 (da) 2000-03-13
CO4230094A1 (es) 1995-10-19
AU6970994A (en) 1994-12-20
HU9503375D0 (en) 1996-01-29
HRP940315A2 (en) 1996-08-31
SI0700290T1 (en) 1999-12-31
GR3031669T3 (en) 2000-02-29
US5741806A (en) 1998-04-21
IE940420A1 (en) 1994-11-30
GB9310756D0 (en) 1993-07-14
BE1007158A3 (fr) 1995-04-11
GB9409835D0 (en) 1994-07-06
KR100297212B1 (ko) 2001-10-24
JPH08510457A (ja) 1996-11-05
EP0700290B1 (en) 1999-08-25
HRP970315A2 (en) 1999-04-30
IT1272990B (it) 1997-07-01
GB2279008B (en) 1997-06-18
ATE183643T1 (de) 1999-09-15
WO1994027599A1 (en) 1994-12-08
ITRM940322A1 (it) 1995-11-24
AU680918B2 (en) 1997-08-14
DE69420266D1 (de) 1999-09-30
NO306448B1 (no) 1999-11-08
RU2132684C1 (ru) 1999-07-10

Similar Documents

Publication Publication Date Title
AP544A (en) Compositions for rectal administration
US5705506A (en) Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration
AU626010B2 (en) Medicaments
EP0345931A1 (en) Certain PAF antagonist/antihistamine combinations and methods
EP0567498A1 (en) Pharmaceutical composition containing granisetron and dexamethasone
JPH05294830A (ja) 直腸投与用のトリアゾール誘導体含有薬剤組成物